Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
771.55 | -48.84% | -27.84% | 694,707.78 | 0.67% | 2.63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
883.20 | 1.22% | 22.21% | 3,934,511.59 | 1.06% | 18.5% |
|
NSEI:SUNPHARMA
Sun Pharmaceutical Industries
|
1494.65 | -16.26% | -4.25% | 3,586,166.01 | 0.82% | 24.54% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.00 | -45.23% | -41.7% | 18,122.25 | 0% | -2.6% |
|
CPSE:ZEAL
Zealand Pharma A/S
|
657.50 | 0% | 0% | 40,945.73 | 0% | 0% |
|
NasdaqGS:HALO
Halozyme Therapeutics
|
43.84 | 25.36% | 47.75% | 5,579.69 | 0% | 44.93% |
|
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.81 | 26.13% | 39.07% | 4,395.55 | 2.92% | 10.04% |
|
NYSE:PBH
Prestige Consumer Healthcare
|
70.32 | -13.91% | -13.16% | 3,491.34 | 0% | 10.29% |
|
NYSE:BHC
Bausch Health Companies
|
6.95 | 146.24% | 169% | 2,549.24 | 0% | -2.74% |
|
NYSE:AMRX
Amneal Pharmaceuticals
|
6.47 | -43.88% | -37.72% | 2,085.83 | 0% | -8.17% |
|
NasdaqGM:SUPN
Supernus Pharmaceuticals
|
30.00 | 2.87% | 17.34% | 1,720.68 | 0% | -11.07% |
|
NasdaqGM:ANIP
ANI Pharmaceuticals
|
65.88 | -23.93% | -11.39% | 1,376.73 | 0% | -1.46% |
|
NasdaqGS:XERS
Xeris Biopharma Holdings
|
1.88 | 0% | 0% | 278.72 | 0% | 0% |
|
NYSE:EBS
Emergent BioSolutions
|
4.37 | 33.09% | 174.9% | 229 | 0% | 0% |
|
NasdaqCM:ASRT
Assertio Holdings
|
1.05 | -,100% | -52.24% | 100.36 | 0% | -35.38% |
|
NasdaqGM:EGRX
Eagle Pharmaceuticals
|
4.66 | 0% | 0% | 60.52 | 0% | 12.41% |
|
NasdaqGM:OPNT
Opiant Pharmaceuticals
|
20.77 | 0% | 0% | 63.99 | 0% | 0% |
|
OTCPK:LCI
Lannett Company
|
0.03 | 0% | 0% | 21.85 | 0% | 0% |
|
OTCPK:ENDP.Q
Endo International
|
0.00 | 199.02% | 285.03% | 1.18 | 0% | -8.52% |
|
NasdaqGS:ACOR
Acorda Therapeutics
|
0.43 | 0% | 0% | 0.53 | 0% | 0% |
